Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination

BACKGROUND AND AIMS: The newly developed direct‐acting antivirals have revolutionized the treatment of chronic hepatitis C virus (HCV), with cure rates as high as 98% in some cohorts. Although genome sequencing has demonstrated that some subtypes of HCV naturally harbor drug resistance associated su...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeboyejo, Kazeem, King, Barnabas J., Tsoleridis, Theocharis, Tarr, Alexander W., McLauchlan, John, Irving, William L., Ball, Jonathan K., McClure, C. Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092547/
https://www.ncbi.nlm.nih.gov/pubmed/36168235
http://dx.doi.org/10.1002/jmv.28178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092547/
https://www.ncbi.nlm.nih.gov/pubmed/36168235
http://dx.doi.org/10.1002/jmv.28178

Ejemplares similares